Gene Therapy Business News

Founded in January 2003, Gene Therapy Research News provides in-depth news of the more than 160 global public and private companies involved in gene therapy research.

Includes research findings, legislation and regulation, experimental therapies, finance and funding, earnings, people, patents, strategic alliances, and much more.

Whether you're a competitor, supplier, investor, analyst, etc. -- if your professional life requires reliable, independent intelligence on stem cell research companies, you should subscribe today to Gene Therapy Research News!

The only independent biweekly report that covers research, legislative, regulatory, and commercialization news.

For-profit rate: US$295.00. PDF only. This is the basic rate for public and private companies. BONUS: Your paid corporate subscription includes either a free copy of the current edition of Who's Who in Stem Cell Research (PDF only) OR a free copy of the Guide to Stem Cell Research Companies (PDF version only). Each is a $249 value.

Order a corporate (for-profit) subscription: Click here.

Nonprofit rate: $219.00. PDF or print. Free bonus report: Who's Who in Stem Cell Research (PDF only) OR a free copy of the Guide to Stem Cell Research Companies (PDF version only). Each is a $249.00 value.

Order a nonprofit subscription (schools, colleges, hospitals, etc.): Click here.

View a sample issue: Click here. NOTE: To view this PDF file you will need Adobe Acrobat Reader. To download and install this free view software, click on the Adobe icon.